HEATHER JOLICOEUR: Open Payments
NPI 1760856827 · NEW MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 29 payments from 12 companies in 2025. Trend: 2023 $584 · 2024 $744 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $250 |
| PFIZER INC. | 3 | $60 |
| Janssen Biotech, Inc. | 2 | $36 |
| UCB, Inc. | 1 | $33 |
| LEO Pharma Inc. | 1 | $32 |
| Amgen Inc. | 1 | $31 |
| GENZYME CORPORATION | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $18 |
Products named: SKYRIZI, CIBINQO, RINVOQ, DUPIXENT, TREMFYA, Bimzelx, ADBRY, OTEZLA.
Industry payments across CT — which companies pay providers there.
